Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 3Completed 1

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1Hypoxia 1Head and Neck Neoplasms 1

Interventions

Cisplatin 15Paclitaxel 14Taxes 10Cyclophosphamide 9Carboplatin 9Gemcitabine 7Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Trastuzumab 5Radiotherapy 5Oxaliplatin 5Doxorubicin 5Docetaxel 5Cytarabine 5Capecitabine 5Brachytherapy 5fludarabine 4Rituximab 4Radiotherapy, Intensity-Modulated 4Radiosurgery 4Fluorouracil 4Dexamethasone 4Watchful Waiting 3Radiotherapy, Conformal 3Pemetrexed 3Nimorazole 3Lenalidomide 3Imatinib Mesylate 3Idarubicin 3Gene Expression Profiling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × NETWORK × Nimorazole × Clear all
NCT01880359 2022-05-10

AF CRT +/- Nimorazole in HNSCC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
640 enrolled
Head & Neck

Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers

NCT02661152 2021-04-13

DAHANCA30

Danish Head and Neck Cancer Group

Phase 3 Unknown
1,252 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

NCT03981068 2020-09-25

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Danish Head and Neck Cancer Group

Phase NA Unknown
20 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡